Clozapine administration in clinical practice

once-daily versus divided dosing

Hiroyoshi Takeuchi, V. Powell, S. Geisler, M. DeSanti, G. Fervaha, O. Agid, J. M. Kane, G. Remington

Research output: Contribution to journalArticle

Abstract

Objective: While it is recommended that clozapine be administered in a divided dosing regimen, it is unclear whether this recommendation is followed in real-world clinical practice. In two large datasets, we examined clozapine dosing frequency and patient characteristics across different dosing regimens. Method: We conducted a cross-sectional survey, collecting data on patients receiving clozapine in August/September 2015 from the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, and The Zucker Hillside Hospital (ZHH) in New York, United States. Results: Of 676 and 308 patients included in CAMH and ZHH datasets, clozapine was prescribed once daily in 75.1% and 74.4%, even though doses exceeding 200 mg/day were administered in 88.6% and 84.4% of the respective samples. No significant difference was found in the rates of positive symptom remission between once-daily vs. divided dosing (79.7% vs. 80.5%, P = 1.00). Higher clozapine dose and use of anticholinergic medications were significantly associated with divided dosing in both datasets. Older age or male gender was related to divided dosing in CAMH or ZHH dataset respectively. Conclusion: Despite the product monograph recommendation, clozapine is frequently prescribed once daily in North America. Further studies are needed to compare clinical outcomes between once-daily vs. divided clozapine dosing.

Original languageEnglish
Pages (from-to)234-240
Number of pages7
JournalActa Psychiatrica Scandinavica
Volume134
Issue number3
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Clozapine
Mental Health
Cholinergic Antagonists
North America
Canada
Cross-Sectional Studies
Datasets

Keywords

  • clozapine
  • dosing
  • once daily
  • regimen
  • schizophrenia

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Takeuchi, H., Powell, V., Geisler, S., DeSanti, M., Fervaha, G., Agid, O., ... Remington, G. (2016). Clozapine administration in clinical practice: once-daily versus divided dosing. Acta Psychiatrica Scandinavica, 134(3), 234-240. https://doi.org/10.1111/acps.12593

Clozapine administration in clinical practice : once-daily versus divided dosing. / Takeuchi, Hiroyoshi; Powell, V.; Geisler, S.; DeSanti, M.; Fervaha, G.; Agid, O.; Kane, J. M.; Remington, G.

In: Acta Psychiatrica Scandinavica, Vol. 134, No. 3, 01.09.2016, p. 234-240.

Research output: Contribution to journalArticle

Takeuchi, H, Powell, V, Geisler, S, DeSanti, M, Fervaha, G, Agid, O, Kane, JM & Remington, G 2016, 'Clozapine administration in clinical practice: once-daily versus divided dosing', Acta Psychiatrica Scandinavica, vol. 134, no. 3, pp. 234-240. https://doi.org/10.1111/acps.12593
Takeuchi, Hiroyoshi ; Powell, V. ; Geisler, S. ; DeSanti, M. ; Fervaha, G. ; Agid, O. ; Kane, J. M. ; Remington, G. / Clozapine administration in clinical practice : once-daily versus divided dosing. In: Acta Psychiatrica Scandinavica. 2016 ; Vol. 134, No. 3. pp. 234-240.
@article{3373d38e2db242c5a4136da8eb5d7d12,
title = "Clozapine administration in clinical practice: once-daily versus divided dosing",
abstract = "Objective: While it is recommended that clozapine be administered in a divided dosing regimen, it is unclear whether this recommendation is followed in real-world clinical practice. In two large datasets, we examined clozapine dosing frequency and patient characteristics across different dosing regimens. Method: We conducted a cross-sectional survey, collecting data on patients receiving clozapine in August/September 2015 from the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, and The Zucker Hillside Hospital (ZHH) in New York, United States. Results: Of 676 and 308 patients included in CAMH and ZHH datasets, clozapine was prescribed once daily in 75.1{\%} and 74.4{\%}, even though doses exceeding 200 mg/day were administered in 88.6{\%} and 84.4{\%} of the respective samples. No significant difference was found in the rates of positive symptom remission between once-daily vs. divided dosing (79.7{\%} vs. 80.5{\%}, P = 1.00). Higher clozapine dose and use of anticholinergic medications were significantly associated with divided dosing in both datasets. Older age or male gender was related to divided dosing in CAMH or ZHH dataset respectively. Conclusion: Despite the product monograph recommendation, clozapine is frequently prescribed once daily in North America. Further studies are needed to compare clinical outcomes between once-daily vs. divided clozapine dosing.",
keywords = "clozapine, dosing, once daily, regimen, schizophrenia",
author = "Hiroyoshi Takeuchi and V. Powell and S. Geisler and M. DeSanti and G. Fervaha and O. Agid and Kane, {J. M.} and G. Remington",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/acps.12593",
language = "English",
volume = "134",
pages = "234--240",
journal = "Acta Psychiatrica Scandinavica",
issn = "0001-690X",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Clozapine administration in clinical practice

T2 - once-daily versus divided dosing

AU - Takeuchi, Hiroyoshi

AU - Powell, V.

AU - Geisler, S.

AU - DeSanti, M.

AU - Fervaha, G.

AU - Agid, O.

AU - Kane, J. M.

AU - Remington, G.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objective: While it is recommended that clozapine be administered in a divided dosing regimen, it is unclear whether this recommendation is followed in real-world clinical practice. In two large datasets, we examined clozapine dosing frequency and patient characteristics across different dosing regimens. Method: We conducted a cross-sectional survey, collecting data on patients receiving clozapine in August/September 2015 from the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, and The Zucker Hillside Hospital (ZHH) in New York, United States. Results: Of 676 and 308 patients included in CAMH and ZHH datasets, clozapine was prescribed once daily in 75.1% and 74.4%, even though doses exceeding 200 mg/day were administered in 88.6% and 84.4% of the respective samples. No significant difference was found in the rates of positive symptom remission between once-daily vs. divided dosing (79.7% vs. 80.5%, P = 1.00). Higher clozapine dose and use of anticholinergic medications were significantly associated with divided dosing in both datasets. Older age or male gender was related to divided dosing in CAMH or ZHH dataset respectively. Conclusion: Despite the product monograph recommendation, clozapine is frequently prescribed once daily in North America. Further studies are needed to compare clinical outcomes between once-daily vs. divided clozapine dosing.

AB - Objective: While it is recommended that clozapine be administered in a divided dosing regimen, it is unclear whether this recommendation is followed in real-world clinical practice. In two large datasets, we examined clozapine dosing frequency and patient characteristics across different dosing regimens. Method: We conducted a cross-sectional survey, collecting data on patients receiving clozapine in August/September 2015 from the Centre for Addiction and Mental Health (CAMH) in Toronto, Canada, and The Zucker Hillside Hospital (ZHH) in New York, United States. Results: Of 676 and 308 patients included in CAMH and ZHH datasets, clozapine was prescribed once daily in 75.1% and 74.4%, even though doses exceeding 200 mg/day were administered in 88.6% and 84.4% of the respective samples. No significant difference was found in the rates of positive symptom remission between once-daily vs. divided dosing (79.7% vs. 80.5%, P = 1.00). Higher clozapine dose and use of anticholinergic medications were significantly associated with divided dosing in both datasets. Older age or male gender was related to divided dosing in CAMH or ZHH dataset respectively. Conclusion: Despite the product monograph recommendation, clozapine is frequently prescribed once daily in North America. Further studies are needed to compare clinical outcomes between once-daily vs. divided clozapine dosing.

KW - clozapine

KW - dosing

KW - once daily

KW - regimen

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84981250272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981250272&partnerID=8YFLogxK

U2 - 10.1111/acps.12593

DO - 10.1111/acps.12593

M3 - Article

VL - 134

SP - 234

EP - 240

JO - Acta Psychiatrica Scandinavica

JF - Acta Psychiatrica Scandinavica

SN - 0001-690X

IS - 3

ER -